سعر فورتيموكس بلس قطرة للعين 5 مل 2024

Sterile eye drops combining moxifloxacin 0.5% (fluoroquinolone antibiotic) with dexamethasone 0.1% (corticosteroid).

• Treatment of ocular infections caused by susceptible organisms and prevention of inflammation and infection after ocular surgery.Orchidia Pharmaceutical Industries (manufacturer)

• Dexamethasone component: raised intraocular pressure/glaucoma, cataract, secondary ocular infection, rarely stinging or burning.General active-ingredient information · DailyMed (U.S. NLM)

• Moxifloxacin component: contraindicated in hypersensitivity to moxifloxacin, other quinolones or any component.General active-ingredient information · DailyMed (U.S. NLM)
• Dexamethasone component: contraindicated in epithelial herpes simplex keratitis, acute viral diseases of the cornea and conjunctiva (vaccinia, varicella), mycobacterial and fungal eye infections.General active-ingredient information · DailyMed (U.S. NLM)

• Prolonged corticosteroid use may cause raised intraocular pressure/glaucoma, posterior subcapsular cataract and secondary infection; monitor intraocular pressure if used 10 days or longer; corneal or scleral thinning may lead to perforation.General active-ingredient information · DailyMed (U.S. NLM)
• Serious hypersensitivity reactions have occurred with systemic quinolones; discontinue if allergy occurs. Prolonged use may cause overgrowth of non-susceptible organisms including fungi. Do not wear contact lenses with signs of bacterial conjunctivitis.General active-ingredient information · DailyMed (U.S. NLM)

• Dexamethasone ophthalmic: teratogenic in animals after topical ocular application; use in pregnancy only if benefit justifies risk. Moxifloxacin ophthalmic: no adequate human data; systemic exposure after ocular use is low.General active-ingredient information · DailyMed (U.S. NLM)

English text not available for this section.